Search Results
Search for other papers by Eva Baxter in
Google Scholar
PubMed
Search for other papers by Karolina Windloch in
Google Scholar
PubMed
Search for other papers by Greg Kelly in
Google Scholar
PubMed
Search for other papers by Jason S Lee in
Google Scholar
PubMed
Search for other papers by Frank Gannon in
Google Scholar
PubMed
Cancer Biology and Therapeutics Laboratory, UCD Conway Institute of Biomolecular and Biomedical Science, University College Dublin, Belfield, Dublin, Ireland
Systems Biology Ireland, University College Dublin, Belfield, Dublin, Ireland
Search for other papers by Donal J Brennan in
Google Scholar
PubMed
), SMAD3 (Abcam, ab28379), SMAD3 phospho-Ser423/425 (Abcam, ab52903) and XBP1 (Abcam, ab198999). Mouse xenograft model Six-to-seven-week-old female C.B. 17- SCID mice (Animal Resources Centre, Perth, Australia) either had a 0.72mg/pellet 90-day
Search for other papers by Juan Pablo Petiti in
Google Scholar
PubMed
Search for other papers by Liliana del Valle Sosa in
Google Scholar
PubMed
Search for other papers by Florencia Picech in
Google Scholar
PubMed
Search for other papers by Gabriela Deisi Moyano Crespo in
Google Scholar
PubMed
Search for other papers by Jean Zander Arevalo Rojas in
Google Scholar
PubMed
Search for other papers by Pablo Anibal Pérez in
Google Scholar
PubMed
Search for other papers by Carolina Beatriz Guido in
Google Scholar
PubMed
Search for other papers by Carolina Leimgruber in
Google Scholar
PubMed
Search for other papers by María Eugenia Sabatino in
Google Scholar
PubMed
Search for other papers by Pedro García in
Google Scholar
PubMed
Search for other papers by Verónica Bengio in
Google Scholar
PubMed
Search for other papers by Francisco Roque Papalini in
Google Scholar
PubMed
Search for other papers by Paula Estario in
Google Scholar
PubMed
Search for other papers by Celina Berhard in
Google Scholar
PubMed
Search for other papers by Marcos Villarreal in
Google Scholar
PubMed
Search for other papers by Silvina Gutiérrez in
Google Scholar
PubMed
Search for other papers by Ana Lucía De Paul in
Google Scholar
PubMed
Search for other papers by Jorge Humberto Mukdsi in
Google Scholar
PubMed
Search for other papers by Alicia Inés Torres in
Google Scholar
PubMed
attenuated by the MEK/ERK1/2 pathway by modulating SMAD2/3 phosphorylation ( Petiti et al . 2015 ). TGFB1 signaling is mediated by TGFB type 1 receptor (TBR1) and TBR2. Upon TGFB binding, the TBR2 receptors activate the TBR1 receptors, inducing
Search for other papers by Joanna E Burdette in
Google Scholar
PubMed
Search for other papers by Teresa K Woodruff in
Google Scholar
PubMed
ActRII receptors and stimulate the phosphorylation of the type I receptor, Alk4. Alk4 phosphorylates Smads 2 and 3, which then bind to the coregulatory Smad4, and translocate into the nucleus where they regulate gene transcription. Activin was first
Université Claude Bernard Lyon, CNRS UMR5201, INSERM-INRA U418, INSERM, Groupe d'Etude Recherche, Lyon, France; Faculté de Médecine, Université Lyon 1, Lyon F-69003, France; Laboratoire Génétique Moléculaire, Signalisation et Cancer, 8 Avenue Rockefeller, Lyon F-69373, France
Search for other papers by Nader Hussein in
Google Scholar
PubMed
Université Claude Bernard Lyon, CNRS UMR5201, INSERM-INRA U418, INSERM, Groupe d'Etude Recherche, Lyon, France; Faculté de Médecine, Université Lyon 1, Lyon F-69003, France; Laboratoire Génétique Moléculaire, Signalisation et Cancer, 8 Avenue Rockefeller, Lyon F-69373, France
Search for other papers by JieLi Lu in
Google Scholar
PubMed
Université Claude Bernard Lyon, CNRS UMR5201, INSERM-INRA U418, INSERM, Groupe d'Etude Recherche, Lyon, France; Faculté de Médecine, Université Lyon 1, Lyon F-69003, France; Laboratoire Génétique Moléculaire, Signalisation et Cancer, 8 Avenue Rockefeller, Lyon F-69373, France
Search for other papers by Huguette Casse in
Google Scholar
PubMed
Université Claude Bernard Lyon, CNRS UMR5201, INSERM-INRA U418, INSERM, Groupe d'Etude Recherche, Lyon, France; Faculté de Médecine, Université Lyon 1, Lyon F-69003, France; Laboratoire Génétique Moléculaire, Signalisation et Cancer, 8 Avenue Rockefeller, Lyon F-69373, France
Search for other papers by Sandra Fontanière in
Google Scholar
PubMed
Search for other papers by Anne-Marie Morera in
Google Scholar
PubMed
Search for other papers by Séverine Mazaud Guittot in
Google Scholar
PubMed
Université Claude Bernard Lyon, CNRS UMR5201, INSERM-INRA U418, INSERM, Groupe d'Etude Recherche, Lyon, France; Faculté de Médecine, Université Lyon 1, Lyon F-69003, France; Laboratoire Génétique Moléculaire, Signalisation et Cancer, 8 Avenue Rockefeller, Lyon F-69373, France
Université Claude Bernard Lyon, CNRS UMR5201, INSERM-INRA U418, INSERM, Groupe d'Etude Recherche, Lyon, France; Faculté de Médecine, Université Lyon 1, Lyon F-69003, France; Laboratoire Génétique Moléculaire, Signalisation et Cancer, 8 Avenue Rockefeller, Lyon F-69373, France
Search for other papers by Alain Calender in
Google Scholar
PubMed
Search for other papers by Nathalie Di Clemente in
Google Scholar
PubMed
Université Claude Bernard Lyon, CNRS UMR5201, INSERM-INRA U418, INSERM, Groupe d'Etude Recherche, Lyon, France; Faculté de Médecine, Université Lyon 1, Lyon F-69003, France; Laboratoire Génétique Moléculaire, Signalisation et Cancer, 8 Avenue Rockefeller, Lyon F-69373, France
Université Claude Bernard Lyon, CNRS UMR5201, INSERM-INRA U418, INSERM, Groupe d'Etude Recherche, Lyon, France; Faculté de Médecine, Université Lyon 1, Lyon F-69003, France; Laboratoire Génétique Moléculaire, Signalisation et Cancer, 8 Avenue Rockefeller, Lyon F-69373, France
Search for other papers by Chang X Zhang in
Google Scholar
PubMed
-β/BMP pathway, Smad1, 3 and 5, in various cell types and tissues ( Kaji et al . 2001 , Sowa et al . 2003 ), we decided to investigate whether there is a common molecular basis among LCTs developed in heterozygous Men1 mice and those found in mice with
Search for other papers by Xinyu Wu in
Google Scholar
PubMed
Department of Pathology, Arthritis and Tissue Degeneration Program, Laboratory of Molecular Biology, Department of Pathology, Department of Urology, NYU Cancer Institute, New York Harbor Healthcare System, Department of Urology, New York University School of Medicine, New York, NY, USA
Search for other papers by Shiaoching Gong in
Google Scholar
PubMed
Search for other papers by Pradip Roy-Burman in
Google Scholar
PubMed
Department of Pathology, Arthritis and Tissue Degeneration Program, Laboratory of Molecular Biology, Department of Pathology, Department of Urology, NYU Cancer Institute, New York Harbor Healthcare System, Department of Urology, New York University School of Medicine, New York, NY, USA
Department of Pathology, Arthritis and Tissue Degeneration Program, Laboratory of Molecular Biology, Department of Pathology, Department of Urology, NYU Cancer Institute, New York Harbor Healthcare System, Department of Urology, New York University School of Medicine, New York, NY, USA
Department of Pathology, Arthritis and Tissue Degeneration Program, Laboratory of Molecular Biology, Department of Pathology, Department of Urology, NYU Cancer Institute, New York Harbor Healthcare System, Department of Urology, New York University School of Medicine, New York, NY, USA
Search for other papers by Peng Lee in
Google Scholar
PubMed
Search for other papers by Zoran Culig in
Google Scholar
PubMed
. Prostate tumor growth in xenograft models Cell lines commonly used in xenograft models The most commonly used cell lines for prostate xenograft models ( Table 1 ) are LNCaP, PC3, and DU145. The LNCaP cell line is a androgen-sensitive human PCa cell line
Institute of Pathology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Institute for Pathology University Hospital Basel, Basel, Switzerland
Department of Urology St. Claraspital, Basel, Switzerland
Department of Urology University Hospital Basel, Basel, Switzerland
Department of Urology University Hospital of Örebro, Örebro, Sweden
School of Health and Medical Sciences Örebro University, Örebro, Sweden
Center for Genomics and Transcriptomics CeGaT GmbH, Tuebingen, Germany
Clinic for Urology and Pediatric Urology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Section of Molecular Urooncology Department of Urology, School of Medicine, University of Heidelberg, Heidelberg, Germany
Department of Prostate Cancer Research
Institute of Pathology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Institute for Pathology University Hospital Basel, Basel, Switzerland
Department of Urology St. Claraspital, Basel, Switzerland
Department of Urology University Hospital Basel, Basel, Switzerland
Department of Urology University Hospital of Örebro, Örebro, Sweden
School of Health and Medical Sciences Örebro University, Örebro, Sweden
Center for Genomics and Transcriptomics CeGaT GmbH, Tuebingen, Germany
Clinic for Urology and Pediatric Urology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Section of Molecular Urooncology Department of Urology, School of Medicine, University of Heidelberg, Heidelberg, Germany
Search for other papers by David Adler in
Google Scholar
PubMed
Institute of Pathology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Institute for Pathology University Hospital Basel, Basel, Switzerland
Department of Urology St. Claraspital, Basel, Switzerland
Department of Urology University Hospital Basel, Basel, Switzerland
Department of Urology University Hospital of Örebro, Örebro, Sweden
School of Health and Medical Sciences Örebro University, Örebro, Sweden
Center for Genomics and Transcriptomics CeGaT GmbH, Tuebingen, Germany
Clinic for Urology and Pediatric Urology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Section of Molecular Urooncology Department of Urology, School of Medicine, University of Heidelberg, Heidelberg, Germany
Department of Prostate Cancer Research
Institute of Pathology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Institute for Pathology University Hospital Basel, Basel, Switzerland
Department of Urology St. Claraspital, Basel, Switzerland
Department of Urology University Hospital Basel, Basel, Switzerland
Department of Urology University Hospital of Örebro, Örebro, Sweden
School of Health and Medical Sciences Örebro University, Örebro, Sweden
Center for Genomics and Transcriptomics CeGaT GmbH, Tuebingen, Germany
Clinic for Urology and Pediatric Urology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Section of Molecular Urooncology Department of Urology, School of Medicine, University of Heidelberg, Heidelberg, Germany
Search for other papers by Anne Offermann in
Google Scholar
PubMed
Institute of Pathology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Institute for Pathology University Hospital Basel, Basel, Switzerland
Department of Urology St. Claraspital, Basel, Switzerland
Department of Urology University Hospital Basel, Basel, Switzerland
Department of Urology University Hospital of Örebro, Örebro, Sweden
School of Health and Medical Sciences Örebro University, Örebro, Sweden
Center for Genomics and Transcriptomics CeGaT GmbH, Tuebingen, Germany
Clinic for Urology and Pediatric Urology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Section of Molecular Urooncology Department of Urology, School of Medicine, University of Heidelberg, Heidelberg, Germany
Department of Prostate Cancer Research
Institute of Pathology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Institute for Pathology University Hospital Basel, Basel, Switzerland
Department of Urology St. Claraspital, Basel, Switzerland
Department of Urology University Hospital Basel, Basel, Switzerland
Department of Urology University Hospital of Örebro, Örebro, Sweden
School of Health and Medical Sciences Örebro University, Örebro, Sweden
Center for Genomics and Transcriptomics CeGaT GmbH, Tuebingen, Germany
Clinic for Urology and Pediatric Urology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Section of Molecular Urooncology Department of Urology, School of Medicine, University of Heidelberg, Heidelberg, Germany
Search for other papers by Martin Braun in
Google Scholar
PubMed
Institute of Pathology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Institute for Pathology University Hospital Basel, Basel, Switzerland
Department of Urology St. Claraspital, Basel, Switzerland
Department of Urology University Hospital Basel, Basel, Switzerland
Department of Urology University Hospital of Örebro, Örebro, Sweden
School of Health and Medical Sciences Örebro University, Örebro, Sweden
Center for Genomics and Transcriptomics CeGaT GmbH, Tuebingen, Germany
Clinic for Urology and Pediatric Urology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Section of Molecular Urooncology Department of Urology, School of Medicine, University of Heidelberg, Heidelberg, Germany
Department of Prostate Cancer Research
Institute of Pathology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Institute for Pathology University Hospital Basel, Basel, Switzerland
Department of Urology St. Claraspital, Basel, Switzerland
Department of Urology University Hospital Basel, Basel, Switzerland
Department of Urology University Hospital of Örebro, Örebro, Sweden
School of Health and Medical Sciences Örebro University, Örebro, Sweden
Center for Genomics and Transcriptomics CeGaT GmbH, Tuebingen, Germany
Clinic for Urology and Pediatric Urology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Section of Molecular Urooncology Department of Urology, School of Medicine, University of Heidelberg, Heidelberg, Germany
Search for other papers by Roopika Menon in
Google Scholar
PubMed
Institute of Pathology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Institute for Pathology University Hospital Basel, Basel, Switzerland
Department of Urology St. Claraspital, Basel, Switzerland
Department of Urology University Hospital Basel, Basel, Switzerland
Department of Urology University Hospital of Örebro, Örebro, Sweden
School of Health and Medical Sciences Örebro University, Örebro, Sweden
Center for Genomics and Transcriptomics CeGaT GmbH, Tuebingen, Germany
Clinic for Urology and Pediatric Urology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Section of Molecular Urooncology Department of Urology, School of Medicine, University of Heidelberg, Heidelberg, Germany
Department of Prostate Cancer Research
Institute of Pathology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Institute for Pathology University Hospital Basel, Basel, Switzerland
Department of Urology St. Claraspital, Basel, Switzerland
Department of Urology University Hospital Basel, Basel, Switzerland
Department of Urology University Hospital of Örebro, Örebro, Sweden
School of Health and Medical Sciences Örebro University, Örebro, Sweden
Center for Genomics and Transcriptomics CeGaT GmbH, Tuebingen, Germany
Clinic for Urology and Pediatric Urology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Section of Molecular Urooncology Department of Urology, School of Medicine, University of Heidelberg, Heidelberg, Germany
Department of Prostate Cancer Research
Institute of Pathology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Institute for Pathology University Hospital Basel, Basel, Switzerland
Department of Urology St. Claraspital, Basel, Switzerland
Department of Urology University Hospital Basel, Basel, Switzerland
Department of Urology University Hospital of Örebro, Örebro, Sweden
School of Health and Medical Sciences Örebro University, Örebro, Sweden
Center for Genomics and Transcriptomics CeGaT GmbH, Tuebingen, Germany
Clinic for Urology and Pediatric Urology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Section of Molecular Urooncology Department of Urology, School of Medicine, University of Heidelberg, Heidelberg, Germany
Search for other papers by Isabella Syring in
Google Scholar
PubMed
Institute of Pathology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Institute for Pathology University Hospital Basel, Basel, Switzerland
Department of Urology St. Claraspital, Basel, Switzerland
Department of Urology University Hospital Basel, Basel, Switzerland
Department of Urology University Hospital of Örebro, Örebro, Sweden
School of Health and Medical Sciences Örebro University, Örebro, Sweden
Center for Genomics and Transcriptomics CeGaT GmbH, Tuebingen, Germany
Clinic for Urology and Pediatric Urology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Section of Molecular Urooncology Department of Urology, School of Medicine, University of Heidelberg, Heidelberg, Germany
Department of Prostate Cancer Research
Institute of Pathology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Institute for Pathology University Hospital Basel, Basel, Switzerland
Department of Urology St. Claraspital, Basel, Switzerland
Department of Urology University Hospital Basel, Basel, Switzerland
Department of Urology University Hospital of Örebro, Örebro, Sweden
School of Health and Medical Sciences Örebro University, Örebro, Sweden
Center for Genomics and Transcriptomics CeGaT GmbH, Tuebingen, Germany
Clinic for Urology and Pediatric Urology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Section of Molecular Urooncology Department of Urology, School of Medicine, University of Heidelberg, Heidelberg, Germany
Search for other papers by Michael Nowak in
Google Scholar
PubMed
Institute of Pathology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Institute for Pathology University Hospital Basel, Basel, Switzerland
Department of Urology St. Claraspital, Basel, Switzerland
Department of Urology University Hospital Basel, Basel, Switzerland
Department of Urology University Hospital of Örebro, Örebro, Sweden
School of Health and Medical Sciences Örebro University, Örebro, Sweden
Center for Genomics and Transcriptomics CeGaT GmbH, Tuebingen, Germany
Clinic for Urology and Pediatric Urology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Section of Molecular Urooncology Department of Urology, School of Medicine, University of Heidelberg, Heidelberg, Germany
Department of Prostate Cancer Research
Institute of Pathology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Institute for Pathology University Hospital Basel, Basel, Switzerland
Department of Urology St. Claraspital, Basel, Switzerland
Department of Urology University Hospital Basel, Basel, Switzerland
Department of Urology University Hospital of Örebro, Örebro, Sweden
School of Health and Medical Sciences Örebro University, Örebro, Sweden
Center for Genomics and Transcriptomics CeGaT GmbH, Tuebingen, Germany
Clinic for Urology and Pediatric Urology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Section of Molecular Urooncology Department of Urology, School of Medicine, University of Heidelberg, Heidelberg, Germany
Search for other papers by Rebecca Halbach in
Google Scholar
PubMed
Institute of Pathology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Institute for Pathology University Hospital Basel, Basel, Switzerland
Department of Urology St. Claraspital, Basel, Switzerland
Department of Urology University Hospital Basel, Basel, Switzerland
Department of Urology University Hospital of Örebro, Örebro, Sweden
School of Health and Medical Sciences Örebro University, Örebro, Sweden
Center for Genomics and Transcriptomics CeGaT GmbH, Tuebingen, Germany
Clinic for Urology and Pediatric Urology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Section of Molecular Urooncology Department of Urology, School of Medicine, University of Heidelberg, Heidelberg, Germany
Department of Prostate Cancer Research
Institute of Pathology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Institute for Pathology University Hospital Basel, Basel, Switzerland
Department of Urology St. Claraspital, Basel, Switzerland
Department of Urology University Hospital Basel, Basel, Switzerland
Department of Urology University Hospital of Örebro, Örebro, Sweden
School of Health and Medical Sciences Örebro University, Örebro, Sweden
Center for Genomics and Transcriptomics CeGaT GmbH, Tuebingen, Germany
Clinic for Urology and Pediatric Urology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Section of Molecular Urooncology Department of Urology, School of Medicine, University of Heidelberg, Heidelberg, Germany
Search for other papers by Wenzel Vogel in
Google Scholar
PubMed
Institute of Pathology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Institute for Pathology University Hospital Basel, Basel, Switzerland
Department of Urology St. Claraspital, Basel, Switzerland
Department of Urology University Hospital Basel, Basel, Switzerland
Department of Urology University Hospital of Örebro, Örebro, Sweden
School of Health and Medical Sciences Örebro University, Örebro, Sweden
Center for Genomics and Transcriptomics CeGaT GmbH, Tuebingen, Germany
Clinic for Urology and Pediatric Urology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Section of Molecular Urooncology Department of Urology, School of Medicine, University of Heidelberg, Heidelberg, Germany
Search for other papers by Christian Ruiz in
Google Scholar
PubMed
Institute of Pathology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Institute for Pathology University Hospital Basel, Basel, Switzerland
Department of Urology St. Claraspital, Basel, Switzerland
Department of Urology University Hospital Basel, Basel, Switzerland
Department of Urology University Hospital of Örebro, Örebro, Sweden
School of Health and Medical Sciences Örebro University, Örebro, Sweden
Center for Genomics and Transcriptomics CeGaT GmbH, Tuebingen, Germany
Clinic for Urology and Pediatric Urology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Section of Molecular Urooncology Department of Urology, School of Medicine, University of Heidelberg, Heidelberg, Germany
Search for other papers by Tobias Zellweger in
Google Scholar
PubMed
Institute of Pathology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Institute for Pathology University Hospital Basel, Basel, Switzerland
Department of Urology St. Claraspital, Basel, Switzerland
Department of Urology University Hospital Basel, Basel, Switzerland
Department of Urology University Hospital of Örebro, Örebro, Sweden
School of Health and Medical Sciences Örebro University, Örebro, Sweden
Center for Genomics and Transcriptomics CeGaT GmbH, Tuebingen, Germany
Clinic for Urology and Pediatric Urology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Section of Molecular Urooncology Department of Urology, School of Medicine, University of Heidelberg, Heidelberg, Germany
Search for other papers by Cyrill A Rentsch in
Google Scholar
PubMed
Institute of Pathology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Institute for Pathology University Hospital Basel, Basel, Switzerland
Department of Urology St. Claraspital, Basel, Switzerland
Department of Urology University Hospital Basel, Basel, Switzerland
Department of Urology University Hospital of Örebro, Örebro, Sweden
School of Health and Medical Sciences Örebro University, Örebro, Sweden
Center for Genomics and Transcriptomics CeGaT GmbH, Tuebingen, Germany
Clinic for Urology and Pediatric Urology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Section of Molecular Urooncology Department of Urology, School of Medicine, University of Heidelberg, Heidelberg, Germany
Search for other papers by Maria Svensson in
Google Scholar
PubMed
Institute of Pathology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Institute for Pathology University Hospital Basel, Basel, Switzerland
Department of Urology St. Claraspital, Basel, Switzerland
Department of Urology University Hospital Basel, Basel, Switzerland
Department of Urology University Hospital of Örebro, Örebro, Sweden
School of Health and Medical Sciences Örebro University, Örebro, Sweden
Center for Genomics and Transcriptomics CeGaT GmbH, Tuebingen, Germany
Clinic for Urology and Pediatric Urology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Section of Molecular Urooncology Department of Urology, School of Medicine, University of Heidelberg, Heidelberg, Germany
Department of Prostate Cancer Research
Institute of Pathology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Institute for Pathology University Hospital Basel, Basel, Switzerland
Department of Urology St. Claraspital, Basel, Switzerland
Department of Urology University Hospital Basel, Basel, Switzerland
Department of Urology University Hospital of Örebro, Örebro, Sweden
School of Health and Medical Sciences Örebro University, Örebro, Sweden
Center for Genomics and Transcriptomics CeGaT GmbH, Tuebingen, Germany
Clinic for Urology and Pediatric Urology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Section of Molecular Urooncology Department of Urology, School of Medicine, University of Heidelberg, Heidelberg, Germany
Search for other papers by Ove Andren in
Google Scholar
PubMed
Institute of Pathology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Institute for Pathology University Hospital Basel, Basel, Switzerland
Department of Urology St. Claraspital, Basel, Switzerland
Department of Urology University Hospital Basel, Basel, Switzerland
Department of Urology University Hospital of Örebro, Örebro, Sweden
School of Health and Medical Sciences Örebro University, Örebro, Sweden
Center for Genomics and Transcriptomics CeGaT GmbH, Tuebingen, Germany
Clinic for Urology and Pediatric Urology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Section of Molecular Urooncology Department of Urology, School of Medicine, University of Heidelberg, Heidelberg, Germany
Search for other papers by Lukas Bubendorf in
Google Scholar
PubMed
Institute of Pathology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Institute for Pathology University Hospital Basel, Basel, Switzerland
Department of Urology St. Claraspital, Basel, Switzerland
Department of Urology University Hospital Basel, Basel, Switzerland
Department of Urology University Hospital of Örebro, Örebro, Sweden
School of Health and Medical Sciences Örebro University, Örebro, Sweden
Center for Genomics and Transcriptomics CeGaT GmbH, Tuebingen, Germany
Clinic for Urology and Pediatric Urology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Section of Molecular Urooncology Department of Urology, School of Medicine, University of Heidelberg, Heidelberg, Germany
Search for other papers by Saskia Biskup in
Google Scholar
PubMed
Institute of Pathology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Institute for Pathology University Hospital Basel, Basel, Switzerland
Department of Urology St. Claraspital, Basel, Switzerland
Department of Urology University Hospital Basel, Basel, Switzerland
Department of Urology University Hospital of Örebro, Örebro, Sweden
School of Health and Medical Sciences Örebro University, Örebro, Sweden
Center for Genomics and Transcriptomics CeGaT GmbH, Tuebingen, Germany
Clinic for Urology and Pediatric Urology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Section of Molecular Urooncology Department of Urology, School of Medicine, University of Heidelberg, Heidelberg, Germany
Search for other papers by Stefan Duensing in
Google Scholar
PubMed
Institute of Pathology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Institute for Pathology University Hospital Basel, Basel, Switzerland
Department of Urology St. Claraspital, Basel, Switzerland
Department of Urology University Hospital Basel, Basel, Switzerland
Department of Urology University Hospital of Örebro, Örebro, Sweden
School of Health and Medical Sciences Örebro University, Örebro, Sweden
Center for Genomics and Transcriptomics CeGaT GmbH, Tuebingen, Germany
Clinic for Urology and Pediatric Urology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Section of Molecular Urooncology Department of Urology, School of Medicine, University of Heidelberg, Heidelberg, Germany
Search for other papers by Jutta Kirfel in
Google Scholar
PubMed
Institute of Pathology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Institute for Pathology University Hospital Basel, Basel, Switzerland
Department of Urology St. Claraspital, Basel, Switzerland
Department of Urology University Hospital Basel, Basel, Switzerland
Department of Urology University Hospital of Örebro, Örebro, Sweden
School of Health and Medical Sciences Örebro University, Örebro, Sweden
Center for Genomics and Transcriptomics CeGaT GmbH, Tuebingen, Germany
Clinic for Urology and Pediatric Urology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Section of Molecular Urooncology Department of Urology, School of Medicine, University of Heidelberg, Heidelberg, Germany
Department of Prostate Cancer Research
Institute of Pathology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Institute for Pathology University Hospital Basel, Basel, Switzerland
Department of Urology St. Claraspital, Basel, Switzerland
Department of Urology University Hospital Basel, Basel, Switzerland
Department of Urology University Hospital of Örebro, Örebro, Sweden
School of Health and Medical Sciences Örebro University, Örebro, Sweden
Center for Genomics and Transcriptomics CeGaT GmbH, Tuebingen, Germany
Clinic for Urology and Pediatric Urology University Hospital of Bonn, Sigmund‐Freud Strasse 25, 53127 Bonn, Germany
Section of Molecular Urooncology Department of Urology, School of Medicine, University of Heidelberg, Heidelberg, Germany
Search for other papers by Sven Perner in
Google Scholar
PubMed
-phospho (S423+S425)-SMAD3 rabbit MAB (1:1000, EP823Y, Abcam, Cambridge, UK), anti-β-actin MAB (1:5000, A1978, Sigma Aldrich, St Louis, MO, USA), and anti-Vimentin rabbit monoclonal (1:1000, 3932, Cell Signaling) primary antibodies at 4 °C overnight. The
Search for other papers by Sonia D'Inzeo in
Google Scholar
PubMed
Search for other papers by Arianna Nicolussi in
Google Scholar
PubMed
Search for other papers by Caterina Francesca Donini in
Google Scholar
PubMed
Search for other papers by Massimo Zani in
Google Scholar
PubMed
Search for other papers by Patrizia Mancini in
Google Scholar
PubMed
Departments of, Experimental Medicine, Molecular Medicine, Radiological Sciences, Oncology and Anatomical Pathology, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy
Search for other papers by Francesco Nardi in
Google Scholar
PubMed
Search for other papers by Anna Coppa in
Google Scholar
PubMed
1998 ). TGFβ ligands bind to heterotetrameric complexes of receptors with serine–threonine kinase activity, leading to an increase in their ability to phosphorylate receptor-regulated Smads (R-Smads). The phosphorylation of R-Smads (Smad2 and Smad3) by
Search for other papers by Eric Glasgow in
Google Scholar
PubMed
Laboratory of Cancer Genetics, Veterans Affairs Medical Center, Digestive Diseases, and GI Developmental Biology, Department of Surgery, Medicine and Lombardi Cancer Center, Georgetown University Medical Center, Medical/Dental Building, NW 213, 3900 Reservoir Road, NW, Washington, District of Columbia 20007, USA
Search for other papers by Lopa Mishra in
Google Scholar
PubMed
) falling into three functional classes: i) receptor-activated Smads (R-Smads): Smad1, Smad2, Smad3, Smad5, and Smad8; ii) co-mediator Smads: Smad4 and Smad 10; and iii) inhibitory Smads (I-Smads): Smad6 and Smad7. Activation of the TGF-β receptor complex by
Search for other papers by Christina Schug in
Google Scholar
PubMed
Search for other papers by Sarah Urnauer in
Google Scholar
PubMed
Search for other papers by Carsten Jaeckel in
Google Scholar
PubMed
Search for other papers by Kathrin A Schmohl in
Google Scholar
PubMed
Search for other papers by Mariella Tutter in
Google Scholar
PubMed
Search for other papers by Katja Steiger in
Google Scholar
PubMed
Search for other papers by Nathalie Schwenk in
Google Scholar
PubMed
Search for other papers by Markus Schwaiger in
Google Scholar
PubMed
Search for other papers by Ernst Wagner in
Google Scholar
PubMed
Search for other papers by Peter J Nelson in
Google Scholar
PubMed
Search for other papers by Christine Spitzweg in
Google Scholar
PubMed
. 1994 , Massague 1998 , Derynck et al. 2001 ). Activated SMAD2 and SMAD3 form heterotrimeric complexes with the signal mediator SMAD4. The complex translocates to the nucleus to modulate transcription of target genes. Inhibitory SMADs, such as SMAD6
Search for other papers by D S Saloman in
Google Scholar
PubMed
Search for other papers by C Bianco in
Google Scholar
PubMed
Search for other papers by A D Ebert in
Google Scholar
PubMed
Search for other papers by N I Khan in
Google Scholar
PubMed
Search for other papers by M De Santis in
Google Scholar
PubMed
Search for other papers by N Normanno in
Google Scholar
PubMed
Search for other papers by C Wechselberger in
Google Scholar
PubMed
Search for other papers by M Seno in
Google Scholar
PubMed
Search for other papers by K Williams in
Google Scholar
PubMed
Search for other papers by M Sanicola in
Google Scholar
PubMed
Search for other papers by S Foley in
Google Scholar
PubMed
Search for other papers by W J Gullick in
Google Scholar
PubMed
Search for other papers by G Persico in
Google Scholar
PubMed
The EGF-CFC gene family encodes a group of structurally related proteins that serve as important competence factors during early embryogenesis in Xenopus, zebrafish, mice and humans. This multigene family consists of Xenopus FRL-1, zebrafish one-eyed-pinhead (oep), mouse cripto (Cr-1) and cryptic, and human cripto (CR-1) and criptin. FRL-1, oep and mouse cripto are essential for the formation of mesoderm and endoderm and for correct establishment of the anterior/posterior axis. In addition, oep and cryptic are important for the establishment of left-right (L/R) asymmetry. In zebrafish, there is strong genetic evidence that oep functions as an obligatory co-factor for the correct signaling of a transforming growth factor-beta (TGFbeta)-related gene, nodal, during gastrulation and during L/R asymmetry development. Expression of Cr-1 and cryptic is extinguished in the embryo after day 8 of gestation except for the developing heart where Cr-1 expression is necessary for myocardial development. In the mouse, cryptic is not expressed in adult tissues whereas Cr-1 is expressed at a low level in several different tissues including the mammary gland. In the mammary gland, expression of Cr-1 in the ductal epithelial cells increases during pregnancy and lactation and immunoreactive and biologically active Cr-1 protein can be detected in human milk. Overexpression of Cr-1 in mouse mammary epithelial cells can facilitate their in vitro transformation and in vivo these Cr-1-transduced cells produce ductal hyperplasias in the mammary gland. Recombinant mouse or human cripto can enhance cell motility and branching morphogenesis in mammary epithelial cells and in some human tumor cells. These effects are accompanied by an epithelial-mesenchymal transition which is associated with a decrease in beta-catenin function and an increase in vimentin expression. Expression of cripto is increased several-fold in human colon, gastric, pancreatic and lung carcinomas and in a variety of different types of mouse and human breast carcinomas. More importantly, this increase can first be detected in premalignant lesions in some of these tissues. Although a specific receptor for the EGF-CFC proteins has not yet been identified, oep depends upon an activin-type RIIB and RIB receptor system that functions through Smad-2. Mouse and human cripto have been shown to activate a ras/raf/MAP kinase signaling pathway in mammary epithelial cells. Activation of phosphatidylinositol 3-kinase and Akt are also important for the ability of CR-1 to stimulate cell migration and to block lactogenic hormone-induced expression of beta-casein and whey acidic protein. In mammary epithelial cells, part of these responses may depend on the ability of CR-1 to transactivate erb B-4 and/or fibroblast growth factor receptor 1 through an src-like tyrosine kinase.